Project GENIE Releases Aggregated Cancer Genomic Data Set | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Project GENIE Releases Aggregated Cancer Genomic Data Set

January 5, 2017
by David Raths
| Reprints
Project includes nearly 19,000 de-identified genomic records
Click To View Gallery

In November 2015 the American Association for Cancer Research (AACR) launched a registry initiative to aggregate participants’ clinical-grade genomic sequencing data to improve patient treatment decisions and catalyze clinical and translational research. Now AACR has announced the first public release of cancer genomic data aggregated through the initiative.

The data set for AACR’s Project Genomics Evidence Neoplasia Information Exchange (GENIE) includes nearly 19,000 de-identified genomic records collected from patients who were treated at eight international institutions, making it among the largest fully public cancer genomic data sets released to date.

The release includes data for 59 major cancer types, including data on nearly 3,000 patients with lung cancer, more than 2,000 patients with breast cancer, and more than 2,000 patients with colorectal cancer. The genomic data and a limited amount of linked clinical data for each patient can be accessed via the AACR website or downloaded directly from Sage Bionetworks.

“We are excited to make publicly available this very large set of clinical-grade, next-generation sequencing data obtained during routine patient care,” said Charles Sawyers, M.D., Project GENIE Steering Committee chairperson, in a prepared statement.

AACR said there are many ways in which the data can be exploited to benefit patients in the future, including through the validation of gene signatures of drug response or prognosis; the ability to identify new patient populations for drugs previously approved by the U.S. Food and Drug Administration; the expansion of patient populations that will benefit from existing drugs; and the identification of new drug targets and biomarkers.

Sawyers, who is also chairperson of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center in New York and a Howard Hughes Medical Institute investigator, added, “These data were generated as part of routine patient care and without AACR Project GENIE they would likely never have been shared with the global cancer research community. We are committed to sharing not only the real-world data within the AACR Project GENIE registry but also our best practices, from tips about assembling an international consortium to the best variant analysis pipeline, because only by working together will information flow freely and patients benefit rapidly.”

AACR stressed that the newly released data are fully de-identified in compliance with the Health Insurance Portability and Accountability Act (HIPAA). They are derived from patients whose tumors were genetically sequenced as part of their care at one of the eight international institutions that participated in the first phase of AACR Project GENIE.

The eight institutions participating in AACR Project GENIE phase 1 are:

• Dana-Farber Cancer Institute, Boston;

• Gustave Roussy Cancer Campus, Paris-Villejuif-France;

• The Netherlands Cancer Institute, Amsterdam, on behalf of the Center for Personalized Cancer Treatment, Utrecht, The Netherlands;

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore;

•  Memorial Sloan Kettering Cancer Center, New York;

• Princess Margaret Cancer Centre, Toronto;

•  University of Texas MD Anderson Cancer Center, Houston; and,

•  Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

 To expand the AACR Project GENIE registry, the consortium is accepting applications for new participating centers starting Jan. 5, which is a year sooner than originally anticipated. Any nonprofit institution that meets certain criteria can submit an application to become a project participant.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

AHRQ Launches App Challenge for PRO Data Standardization

The Agency for Healthcare Research and Quality (AHRQ) has launched a competition to address the need for greater use of standardized patient-reported outcomes (PRO) data in clinical care and research.

Study: Many U.S. Hospitals won’t Reach HIMSS Stage 7 Until 2035

Unless the healthcare IT ecosystem experiences major policy changes or leaps in technological capabilities, many hospitals will not reach Stage 7 of HIMSS Analytics’ Electronic Medical Record Adoption Model until 2035, according to new research.

Amazon, Google, IBM and Other Tech Giants Pledge to Remove Barriers to Interoperability

Six of the world's biggest technology companies, including Microsoft, Google, IBM and Amazon, made a joint pledge at the White House Monday to remove interoperability barriers and to make progress on adoption of health data standards.

Mayo Clinic Elects New President and CEO

Gianrico Farrugia, M.D., current vice president, Mayo Clinic, and CEO of Mayo Clinic in Florida has been elected as the president and CEO of the Mayo Clinic, headquartered in Minnesota.

Fitbit, Blue Cross Blue Shield Launch Mobile Health Partnership

San Francisco-based fitness wearable maker Fitbit continues its push into the health plan market with a new digital health deal to incorporate its fitness tracker into health and wellness programs.

ASCO Picks IBM Watson Exec to Lead CancerLinQ

The American Society of Clinical Oncology (ASCO) has named a former IBM Watson executive as the new CEO of its CancerLinQ big data platform.